Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 14/20 | 0.49 |
| ▸ | RAB9A | P51151 | 14/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 8/20 | 0.49 |
| ▸ | HPGD | P15428 | 6/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.47 |
| ▸ | GLA | P06280 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.45 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.45 |
| ▸ | RELA | Q04206 | 2/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | ATAD2 | Q6PL18 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 2/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18868444 | 0.88 | NPC1 (0.39) | NPC1RAB9ASMN1; SMN2HPGDALDH1A1 | |
| SCHEMBL17173799 | 0.80 | ALOX15 (0.53) | NPC1RAB9ASMN1; SMN2HPGDALDH1A1 | |
| SCHEMBL18868439 | 0.80 | TSHR (0.53) | NPC1RAB9ASMN1; SMN2HPGDALDH1A1 | |
| SCHEMBL17173792 | 0.78 | ALDH1A1 (0.37) | NPC1RAB9ASMN1; SMN2HPGDALDH1A1 | |
| SCHEMBL18868440 | 0.76 | PDK2 (0.35) | NPC1RAB9ASMN1; SMN2HPGDALDH1A1 | |
| SCHEMBL522555 | 0.74 | NPC1 (0.90) | NPC1RAB9ASMN1; SMN2HPGDALDH1A1 | |
| SCHEMBL22858502 | 0.74 | NPC1 (0.90) | NPC1RAB9ASMN1; SMN2HPGDALDH1A1 | |
| SCHEMBL74999 | 0.74 | NPC1 (0.90) | NPC1RAB9ASMN1; SMN2HPGDALDH1A1 | |
| SCHEMBL46424 | 0.74 | NPC1 (0.90) | NPC1RAB9ASMN1; SMN2HPGDALDH1A1 | |
| SCHEMBL17173791 | 0.74 | RAB9A (0.38) | NPC1RAB9AHPGDALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10804472-B2 | Light-emitting element, light-emitting device, light source, authentication device, and electronic apparatus | SEIKO EPSON CORPORATION (JP) | 2020-10-13 | — | — | US | disclosed |
| US-10431761-B2 | Light-emitting element, light-emitting device, authentication device, and electronic apparatus | SEIKO EPSON CORPORATION (JP) | 2019-10-01 | — | — | US | disclosed |
| US-20170141337-A1 | LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AUTHENTICATION DEVICE, AND ELECTRONIC APPARATUS | LUMITEK DISPLAY TECHNOLOGY LIMITED (IE) | 2017-05-18 | — | — | US | disclosed |
| US-20170141337-A1 | LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AUTHENTICATION DEVICE, AND ELECTRONIC APPARATUS | LUMITEK DISPLAY TECHNOLOGY LIMITED (IE) | 2017-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170141337-A1 | LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AUTHENTICATION DEVICE, AND ELECTRONIC APPARATUS | CYBA, AAAS, UGT1A8 | NPC1 1668/4885RAB9A 2470/4885SMN1; SMN2 2623/4885 |
| US-10431761-B2 | Light-emitting element, light-emitting device, authentication device, and electronic apparatus | CYBA, AAAS, UGT1A8 | NPC1 1668/4885RAB9A 2470/4885SMN1; SMN2 2623/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.